|
Re: Recent rise in SP...
|
2
|
Resverlogix Corp.
|
Sep 28, 2020 12:16PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 03:45PM
|
|
Better than averagd volumd today
|
2
|
Resverlogix Corp.
|
Feb 04, 2019 03:18PM
|
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 20, 2020 09:53AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 11:15AM
|
|
Re: June 21, 2018.
|
2
|
Resverlogix Corp.
|
Jun 09, 2020 12:41PM
|
|
Don't look now but...
|
2
|
Resverlogix Corp.
|
May 08, 2019 09:56AM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 25, 2019 12:48PM
|
|
List of illlnesses our drugs could possibly treat...
|
2
|
Resverlogix Corp.
|
Feb 06, 2019 08:13AM
|
|
Re: One point I want to make clear...
|
2
|
Resverlogix Corp.
|
Feb 14, 2019 10:21PM
|
|
Re: Can Hepalink afford US rights?
|
2
|
Resverlogix Corp.
|
Feb 04, 2019 03:42PM
|
|
The Phase 1 trail CKD in New Zealand
|
2
|
Resverlogix Corp.
|
Apr 02, 2019 12:05PM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 21, 2019 03:07PM
|
|
Re: 48 hours
|
2
|
Resverlogix Corp.
|
Nov 15, 2019 11:45AM
|
|
Re: Volume almost 100,000 at 11am
|
2
|
Resverlogix Corp.
|
Mar 13, 2019 01:06PM
|
|
Re: Continued Roth coverage imo points to a Nasdaq listing....
|
2
|
Resverlogix Corp.
|
May 02, 2019 08:47AM
|
|
Re: Volume almost 100,000 at 11am
|
2
|
Resverlogix Corp.
|
Mar 13, 2019 01:26PM
|
|
Re: Biogen getting hammered
|
2
|
Resverlogix Corp.
|
Dec 04, 2019 04:18PM
|
|
Re: NASH is a $35 Billion US/year market
|
2
|
Resverlogix Corp.
|
Dec 31, 2018 09:49AM
|
|
Re: Well here we are....
|
2
|
Resverlogix Corp.
|
Jan 31, 2019 09:57AM
|
